Watch these on-demand webinars to learn why Thermo Fisher Scientific is the leading single-source supplier for your COVID-19 testing needs.

 

 

Featured webinars

 

The Post-Vaccine COVID Testing Landscape: A Virtual Roundtable Discussion

Watch on demand ›

Molecular Multi-Target Assay Design Coupled with Follow-Up Testing for SARS-CoV-2 Mutations

Watch on demand ›

The importance of simultaneously detecting and differentiating SARS-CoV-2 and influenza during flu season

Watch on demand ›

How to Detect New SARS-CoV-2 Mutations

Watch on demand ›

covidflursv-webinar-promo-graphic

 

Emerging SARS-CoV-2 variants and COVID-19 testing impact

 

Throughout the current global crisis, SARS-CoV-2 has continued to mutate. Discover the importance of these emerging variants and the importance testing plays in the on-demand webinars below.

WebinarCard1

Molecular Multi-Target Assay Design Coupled with Follow-Up Testing for SARS-CoV-2 Mutations

Alan McNally, PhD, Disease Lead for the Milton Keynes Lighthouse Lab UK

Emmanuel André, MD, PhD, Co-Director Infectious Diseases Centre, University Hospital of Leuven

Watch on demand ›

  • The story of detecting B.1.1.7 (UK variant) from a world-leading epidemiologist
  • The importance of early detection of viral variants and the impact of on global response efforts
  • Molecular diagnostic assay design principles to safeguard against unexpected mutations and to monitor for early indicators of emerging variants
  • The S-gene advantage with B.1.1.7 and the value of a targeted mutation panel as a follow-up test to identify a suspected variant
WebinarCard2

Emerging SARS-CoV-2 Mutations: Impact on TaqPath Assay Performance and its Clinical Implications

Peter De Hoff, PhD, Project Scientist, Department of Reproductive Medicine, Sanford Consortium for Regenerative Medicine, UC San Diego

Watch on demand ›

  • Automation and miniaturization of clinical SARS-CoV-2 PCR testing
  • Emerging SARS-CoV-2 mutations: Impact on TaqPath assay performance and the implications
WebinarCard3

Molecular Testing, Strain Identification and Quality Control Strategies for COVID-19 Testing

Manohar R. Furtado, PhD, Director R&D, Genetic Testing Solutions, Thermo Fisher Scientific

Watch on demand ›

  • The importance of testing to lower transmission rates and contain pandemics
  • How mutations emerge and the effect of mutations on SARS-CoV-2 detection assays
  • How to quickly identify emerging mutations and variants

 

SARS-CoV-2 surveillance and mutation confirmation

 

Emerging-Mutation-Surveillance

Think Globally, Act Locally: The Importance of Coordinated Global and Community Genetic Surveillance Programs

Stephen S. Morse, PhD, Columbia University Medical Center

Matthew Avenarius, PhD, Ohio State University Wexner Medical Center

Manoj Ghandi, PhD, Sr. Director, Medical Affairs, Thermo Fisher Scientific

Watch on demand ›

  • An update on the trending variants and explain the risks of the rise of escape mutants
  • Best practices to establish both global and local surveillance programs

 

COVID-19 test portfolio and product performance

 

Testing remains critically important in the fight against COVID-19. As the leader in COVID-19 testing, Thermo Fisher Scientific continues to produce innovative solutions to meet the demands. Watch the on-demand webinars below to see the products in action.

 

TaqPath COVID-19 tests

 

TaqPath-COVID-Combo

Putting the Applied Biosystems TaqPath COVID-19 kit to the test: clinical performance against the competition

Dr. Ninad Mehta, Medical Microbiology, ARUP Laboratories

Watch on demand ›

  • Real-world clinical performance of the TaqPath COVID-19 diagnostic test as compared to two other SARS-CoV-2 molecular diagnostic technologies
  • Thermo Fisher Scientific's expanding COVID-19 testing portfolio
TaqPath-COVID-Combo

Responding to the COVID-19 Outbreak: Global Clinical Performance and Development of the Applied Biosystems TaqPath COVID-19 Assay

Paul A. Granato, PhD, DABMM, FAAM, Professor Emeritus of Pathology at SUNY Upstate Medical University Director of Microbiology at Laboratory Alliance of Central New York

Watch on demand ›

  • Real-world clinical performance of the TaqPath COVID-19 diagnostic test
  • How Thermo Fisher Scientific responded to the SARS-CoV-2 outbreak in the early days of 2020
TaqPath-COVID-Combo

Clinical Laboratory Experience with TaqPath COVID-19 Testing

Scott Hunicke-Smith, PhD, Scientific Director, Clinical Pathology Laboratories

Watch on demand ›

  • How a large reference laboratory operationalized the use of the TaqPath COVID-19 test
  • How one lab manages of supply chain, preanalytical throughput, analytical throughput, and extreme variances in COVID-19 testing demand

 

Thermo Fisher COVID-19 portfolio of tests

 

D1-New-hero-image-(2)

COVID-19 Diagnostics Testing Solutions Addressing Challenges and Pain Points in the Laboratory

Peter Friebe, PhD, Sr Manager, Molecular Biology, Genetic Testing Solutions, Thermo Fisher Scientific

Watch on demand >

  • Thermo Fisher’s complete solution to COVID-19 testing
  • How automation can vastly increase throughput
TaqPath-COVI-19-Pooling

After the Surge: Driving Sample Processing Efficiency of COVID-19 Samples 

Weston Hymas, R&D Scientist, ARUP

Manohar R. Furtado, PhD, Director R&D,Genetic Testing Solutions, Thermo FisherScientific

Watch on demand ›

  • How a SARS-CoV-2 sample pooling protocol can be used to exponentially increase testing efficiency
  • How this method can be implemented in labs for routine processing of samples from populations with low infection rates

 

Workplace testing

 

As employees transition back into the physical workplace, employers are grappling with so many questions pertaining to safety and health for both their employees and their communities. Watch the on-demand webinars below to find the solution that meets your workplace needs.

PG2027-PJT4603-COL111625-PPT-Refresh-COVID-19-response-Americas-F

Overview of COVID-19 Workplace Testing

Mark Stevenson, Executive Vice President and Chief Operating Officer, Thermo Fisher Scientific

Alan Wu, Ph.D., Professor, Lab Medicine UCSF; Co-Core Lab Director, Zuckerberg San Francisco General Hospital

Daniella Cramp, President, Instrument and Enterprise Solutions, Thermo Fisher Scientific

Julia Cheek, CEO and Founder, Everlywell

Watch on demand ›

  • Learn about the difference between diagnostic and antibody testing
  • Gain understanding of different testing modalities to understand what would work best for your organization
  • Discuss the value and rationale for implementing testing in the workplace
  • Hear about Thermo Fisher's and Everlywell’s end-to-end testing solution
safety-wellbeing-webinarcard

Safety and well-being in the workplace

Lisa Britt, Senior Visce President and Chief Human Resources Officer, Thermo Fisher Scientific

Matt Willmon, Sr. Director, Compensation, Thermo Fisher Scientific

Daniella Cramp, President, Instrument and Enterprise Solutions, Thermo Fisher Scientific

Watch on demand ›

  • Discuss the value and rationale for implementing COVID-19 testing in the workplace
  • Hear real-world strategies on workplace testing and policies
  • Gain understanding of Everlywell's turn-key resources for sample collection, test reporting, and result-related actions
  • Share insights on best practices for communicating and implementing a testing program
epidemiology-webinardcard

COVID-19 epidemiology and workplace testing strategies

Kyle Fowler, Vice President, COVID-19 Project Management, LSG, Thermo Fisher Scientific

Alan Sachs, MD, PhD, Chief Scientific Officer, Thermo Fisher Scientific

Judd Walson, MD, MPH, Professor of Global Health, Medicine, Pediatrics and Epidemiology, University of Washington

Watch on demand >

  • Describe screening and surveillance approaches to help guide back-to-work task forces
  • Discuss the latest understanding of SARS-CoV-2 infection in an individual and in a population
  • Describe screening and surveillance approaches to help guide back-to-work task forces
  • Provide considerations for different testing strategies
Intended use and regulatory statements of products vary. For specific intended use and regulatory statements, please refer to the Instructions for Use (IFU). Product availability by country varies. For product availability in your country, visit the product webpage.
Style Sheet for Global Design System